Several scientific studies have demonstrated the therapeutic potential of targeting the NRF2/Kelch‐like ECH‐associated protein 1 (KEAP1) pathway in HI‐induced brain injury [37, 38, 39]. Here, KEAP1 is linked to brain injury.